The last few years have seen the identification of numerous small molecules that selectively inhibit specific class I isoforms of PI3K (phosphoinositide 3-kinase), yet little has been revealed about the molecular basis for the observed selectivities. Using site-directed mutagenesis, we have investigated one of the areas postulated as being critical to the observed selectivity. The residues Thr886 and Lys890 of the PI3Kγ isoform project towards the ATP-binding pocket at the entrance to the catalytic site, but are not conserved. We have made reciprocal mutations between those residues in the β isoform (Glu858 and Asp862) and those in the α isoform (His855 and Gln859) and evaluated the potency of a range of reported PI3K inhibitors. The results show that the potencies of β-selective inhibitors TGX221 and TGX286 are unaffected by this change. In contrast, close analogues of these compounds, particularly the α-isoform-selective compound (III), are markedly influenced by the point mutations. The collected data suggests two distinct binding poses for these inhibitor classes, one of which is associated with potent PI3Kβ activity and is not associated with the mutated residues, and a second that, in accord with earlier hypotheses, does involve this pair of non-conserved amino acids at the catalytic site entrance and contributes to the α-isoform-selectivity of the compounds studied.
Skip Nav Destination
Article navigation
September 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
August 27 2008
Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket
Mark Frazzetto;
Mark Frazzetto
*Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia
Search for other works by this author on:
Cenk Suphioglu;
Cenk Suphioglu
†Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, Burwood, VIC 3125, Australia
Search for other works by this author on:
Jiuxiang Zhu;
Jiuxiang Zhu
‡Johns Hopkins University, Sidney Kimmel Cancer Centre, Baltimore, MD 21231, U.S.A.
Search for other works by this author on:
Oleg Schmidt-Kittler;
Oleg Schmidt-Kittler
‡Johns Hopkins University, Sidney Kimmel Cancer Centre, Baltimore, MD 21231, U.S.A.
Search for other works by this author on:
Ian G. Jennings;
Ian G. Jennings
§Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia
Search for other works by this author on:
Susan L. Cranmer;
Susan L. Cranmer
†Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, Burwood, VIC 3125, Australia
Search for other works by this author on:
Shaun P. Jackson;
Shaun P. Jackson
†Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, Burwood, VIC 3125, Australia
Search for other works by this author on:
Kenneth W. Kinzler;
Kenneth W. Kinzler
‡Johns Hopkins University, Sidney Kimmel Cancer Centre, Baltimore, MD 21231, U.S.A.
Search for other works by this author on:
Bert Vogelstein;
Bert Vogelstein
†Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, Burwood, VIC 3125, Australia
Search for other works by this author on:
Philip E. Thompson
Philip E. Thompson
1
§Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia
1To whom correspondence should be addressed (email Phil.Thompson@vcp.monash.edu.au).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 06 2008
Revision Received:
May 02 2008
Accepted:
May 20 2008
Accepted Manuscript online:
May 20 2008
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2008 Biochemical Society
2008
Biochem J (2008) 414 (3): 383–390.
Article history
Received:
March 06 2008
Revision Received:
May 02 2008
Accepted:
May 20 2008
Accepted Manuscript online:
May 20 2008
Citation
Mark Frazzetto, Cenk Suphioglu, Jiuxiang Zhu, Oleg Schmidt-Kittler, Ian G. Jennings, Susan L. Cranmer, Shaun P. Jackson, Kenneth W. Kinzler, Bert Vogelstein, Philip E. Thompson; Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket. Biochem J 15 September 2008; 414 (3): 383–390. doi: https://doi.org/10.1042/BJ20080512
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.